Treatment in progress...
Close notification

Our telephone...

is currently not working. We're doing all we can to get the problem solved as soon as possible. 
In the meantime, please use e-mail to contact us.

Display notification
FR EN
Back
or use our advanced search function
Your cart is empty.
Picture of Psychiatric and behavioural disorders in children with epilepsy

Psychiatric and behavioural disorders in children with epilepsy

Sillanpää Matti, Gobbi Giuseppe, Dunn David W., Caplan Rochelle, Aldenkamp Albert, Besag Franck M.C.
Publication date 16/03/2017
EAN: 9782742015009
Availability Available from publisher
36.00 €
Psychiatric and behavioural problems are reported to occur in 35-50% of children with epilepsy. They affect the quality of the children's and their families lives in a very challenging manner.The ad hoc Commissions and Taskforces of the International... See full description
Detailed information
Attribute nameAttribute value
Common books attribute
PublisherJOHN LIBBEY
Page Count114
Languageen
AuthorSillanpää Matti, Gobbi Giuseppe, Dunn David W., Caplan Rochelle, Aldenkamp Albert, Besag Franck M.C.
FormatPaperback / softback
Product typeBook
Publication date16/03/2017
Weight268 g
Dimensions (thickness x width x height)0.70 x 17.00 x 24.00 cm
Summary
Report of the child neuropsychiatry taskforce, neuropsychobiology commision, international league against epilepsy
Psychiatric and behavioural problems are reported to occur in 35-50% of children with epilepsy. They affect the quality of the children's and their families lives in a very challenging manner.The ad hoc Commissions and Taskforces of the International League Against Epilepsy are regularly following progress made in the field, also promoting a larger diffusion of existing knowledge and future research.The present report is a state-of-the-art critical review, putting together numerous data concerning topics such as epidemiology, pharmacotherapy, the effects of antiepileptic drugs and epilepsy surgery, the relationships between epilepsy and many psychiatric disorders. It also points out the specific areas in need of controlled trials, such as early diagnosis and management.